Anti-Thyroperoxidase Antibody Levels >500 IU/ml Indicate a Moderately Increased Risk for Developing Hypothyroidism in...

Area of Science:

• Endocrinology and Immunology
• Thyroid Disorders
• Autoimmune Diseases

Background:

• Autoimmune Thyroiditis (AIT) is the most prevalent autoimmune condition, characterized by immune-mediated thyroid destruction.
• The specific contribution of humoral immunity, particularly thyroid antibody levels, to hypothyroidism risk in AIT remains incompletely defined.

Purpose of the Study:

• To investigate the association between serum thyroid antibody levels and the risk of developing hypothyroidism in untreated Autoimmune Thyroiditis patients.
• To determine if specific antibody thresholds or combinations predict hypothyroidism development.

Main Methods:

• Retrospective analysis of 335 untreated Autoimmune Thyroiditis patients.
• Measurement of anti-thyroid peroxidase (TPO) antibodies, anti-thyroglobulin (Tg) antibodies, and thyroid-stimulating hormone (TSH) levels.
• Comparison of TSH levels based on TPO-Ab and Tg-Ab concentrations.

Main Results:

• Patients with TPO-Ab levels exceeding 500 IU/ml demonstrated a moderately increased risk of elevated TSH levels (RR: 1.343, p=0.0023).
• No significant differences in TSH levels were observed for patients with TPO- or Tg-Abs below 100 IU/ml or between 100-500 IU/ml.
• Long-term follow-up of patients with high TPO-Ab levels (>500 IU/ml) showed a statistically significant increase in TSH levels (p=0.0420), though they remained euthyroid.

Conclusions:

• Largely elevated levels of anti-thyroid peroxidase (TPO) antibodies are associated with a moderately increased risk of developing hypothyroidism in Autoimmune Thyroiditis patients.
• Thyroglobulin antibodies, alone or combined with TPO antibodies, did not improve the prediction of hypothyroidism risk.
• Despite elevated TSH, high TPO-Ab levels did not consistently lead to overt hypothyroidism in the observed cohort.